BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 123 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,930 | +0.6% | 1,120 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,885 | -15.6% | 1,120 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9,341 | -27.4% | 1,120 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $12,858 | -1.1% | 1,120 | +9.8% | 0.00% | 0.0% |
| Q3 2022 | $13,000 | +18.2% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -35.3% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $17,000 | +21.4% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $14,000 | -6.7% | 1,020 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $15,000 | -6.2% | 1,020 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $16,000 | +60.0% | 1,020 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $10,000 | – | 1,020 | +1940.0% | 0.00% | – |
| Q4 2020 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 50 | -50.0% | 0.00% | – |
| Q4 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 100 | -33.3% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 150 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 150 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 150 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | -50.0% | 150 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $2,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,000 | +100.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |